24 May 2013
Keywords: exforge, shows, safety, efficacy, bp, study, swiss
Article | 26 February 2007
Swiss drug major Novartis says that data from clinical trials of Exforge (amlodipine and valsartan), its combination antihypertensive medication,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 March 2007
19 February 2007
23 May 2013
© 2013 thepharmaletter.com